0001735276-21-000078.txt : 20210809 0001735276-21-000078.hdr.sgml : 20210809 20210809160949 ACCESSION NUMBER: 0001735276-21-000078 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210806 FILED AS OF DATE: 20210809 DATE AS OF CHANGE: 20210809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greenstreet Yvonne CENTRAL INDEX KEY: 0001446125 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36407 FILM NUMBER: 211156544 MAIL ADDRESS: STREET 1: PACIRA PHARMACEUTICALS, INC. STREET 2: 5 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770602661 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 WEST KENDALL STREET STREET 2: HENRI A. TERMEER SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 551-8200 MAIL ADDRESS: STREET 1: 675 WEST KENDALL STREET STREET 2: HENRI A. TERMEER SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020724 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-08-06 0 0001178670 ALNYLAM PHARMACEUTICALS, INC. ALNY 0001446125 Greenstreet Yvonne 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 0 1 0 0 President & COO Common Stock 2021-08-06 4 M 0 28064 77.1 A 39087 D Common Stock 2021-08-06 4 M 0 25000 77.1 A 64087 D Common Stock 2021-08-06 4 S 0 53064 199.0 D 11023 D Common Stock 407 I by Managed Account Performance Stock Option 2016 (right to buy) 77.1 2021-08-06 4 M 0 25000 0.0 D 2018-08-13 2026-09-18 Common Stock 25000 0 D Stock Option (right to buy) 77.1 2021-08-06 4 M 0 28064 0.0 D 2026-09-18 Common Stock 28064 0 D All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2021. Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Yvonne Greenstreet 2021-08-09